Literature DB >> 21161281

Not ready for prime time: aliskiren for treatment of hypertension or proteinuria in children.

Joseph T Flynn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21161281     DOI： 10.1007/s00467-010-1726-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  7 in total

Review 1.  Paediatric clinical trials: redressing the imbalance.

Authors:  Mark S Schreiner
Journal:  Nat Rev Drug Discov       Date:  2003-12       Impact factor: 84.694

Review 2.  Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.

Authors:  Laura Cuzzolin; Alessandra Atzei; Vassilios Fanos
Journal:  Expert Opin Drug Saf       Date:  2006-09       Impact factor: 4.250

3.  Hypotension after ingestion of Aliskiren.

Authors:  Henry A Spiller
Journal:  Clin Toxicol (Phila)       Date:  2008-11       Impact factor: 4.467

4.  Are we ready to use aliskiren in children?

Authors:  Erin Elizabeth Kelland; Leanne Michelle McAuley; Guido Filler
Journal:  Pediatr Nephrol       Date:  2010-12-11       Impact factor: 3.714

Review 5.  A literature review on off-label drug use in children.

Authors:  Chiara Pandolfini; Maurizio Bonati
Journal:  Eur J Pediatr       Date:  2005-05-24       Impact factor: 3.183

6.  Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.

Authors:  Dan Rakusan; Petr Kujal; Herbert J Kramer; Zuzana Husková; Zdenka Vanourková; Zdenka Vernerová; Iveta Mrázová; Monika Thumová; Ludek Cervenka; Ivana Vanecková
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-28

7.  Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren.

Authors:  Alice Stanton; Chris Jensen; Juerg Nussberger; Eoin O'Brien
Journal:  Hypertension       Date:  2003-11-03       Impact factor: 10.190
  7 in total
  5 in total

Review 1.  Aliskiren, the first direct renin inhibitor: assessing a role in pediatric hypertension and kidney diseases.

Authors:  Shahid Nadeem; Donald L Batisky
Journal:  Pediatr Nephrol       Date:  2013-12-14       Impact factor: 3.714

2.  Should ACE inhibitors and ARBs be used in combination in children?

Authors:  Brian R Stotter; Michael A Ferguson
Journal:  Pediatr Nephrol       Date:  2018-08-15       Impact factor: 3.714

Review 3.  Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options.

Authors:  Damien Noone; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2013-03-08       Impact factor: 3.714

4.  Drug Treatment of Heart Failure in Children: Focus on Recent Recommendations from the ISHLT Guidelines for the Management of Pediatric Heart Failure.

Authors:  Alexander D Hussey; Robert G Weintraub
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

5.  How full is our antihypertensives pipeline?

Authors:  Dilip Gude
Journal:  J Pharmacol Pharmacother       Date:  2012-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.